Stock Analysis
EQT (STO:EQT) First Half 2024 Results
Key Financial Results
- Revenue: €1.23b (up 10% from 1H 2023).
- Net income: €282.0m (up 135% from 1H 2023).
- Profit margin: 23% (up from 11% in 1H 2023).
- EPS: €0.24 (up from €0.10 in 1H 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
EQT Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 5.5%. Earnings per share (EPS) also missed analyst estimates by 46%.
Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Capital Markets industry in Sweden.
Performance of the Swedish Capital Markets industry.
The company's shares are down 6.0% from a week ago.
Risk Analysis
It is worth noting though that we have found 2 warning signs for EQT that you need to take into consideration.
Valuation is complex, but we're here to simplify it.
Discover if EQT might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About OM:EQT
EQT
A global private equity firm specializing in private capital and real asset segments.